Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Equity Subscription

8 May 2025 10:35

RNS Number : 8933H
Symphony Environmental Tech. PLC
08 May 2025
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is considered to be in the public domain.

 

8 May 2025

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

 

("Symphony", the "Group" or the "Company")

 

Equity subscription raising £2.5 million and

total voting rights

 

Symphony Environmental Technologies Plc (AIM: SYM), the global specialist that makes plastic and rubber products "smarter, safer and sustainable", is pleased to announce that it has raised £2.5 million pursuant to an equity subscription for 12,500,000 new ordinary shares of nominal value 1 pence each in the Company ("Ordinary Shares") by Quantum Leap Capital ("Quantum") based in Vermont, USA (the "Subscription").

 

The subscription price is 20 pence per Ordinary Share ("Subscription Price") and upon completion of the Subscription, Quantum will be interested in 5.26 per cent. of the enlarged issued share capital of the Company.

 

The Subscription will complete in two tranches: Tranche A being for 1,250,000 Ordinary Shares and Tranche B for 11,250,000 Ordinary Shares. The Tranche A Ordinary Shares are expected to be admitted to trading on AIM on or around 12 May 2025 ("First Admission") and the Tranche B Ordinary Shares, on or around 9 June 2025 ("Second Admission").

 

The new Ordinary Shares issued pursuant to the Subscription will rank in full for all dividends or other distributions hereafter declared, made or paid on the ordinary share capital of the Company and will rank pari passu in all other respects with all other Ordinary Shares in issue.

 

Total Voting Rights

 

Following First Admission, the total issued share capital of the Company will be 226,349,120 Ordinary Shares. The Company does not hold any shares in treasury and therefore the total number of voting rights in Symphony will be 226,349,120.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules up until Second Admission.

 

Following Second Admission, the total issued share capital of the Company will be 237,599,120 Ordinary Shares. The Company does not hold any shares in treasury and therefore the total number of voting rights in Symphony will be 237,599,120.

 

Use of proceeds

The proceeds of the Subscription will be used for ongoing working capital purposes and Symphony's continuing market development in a range of core complementary technologies. In particular, the Group will contract with GCC Support Services a marketing and advisory organisation which has experience working at high levels with governmental and commercial organisations, to invest in the Middle East region over the next twelve months to:

 

(a) market and sell Symphony's d2w, d2p, and NbR (natural biodegradable resin) products;

(b) devise and execute a public relations and media campaign specifically for the region;

(c) lobby for positive legislation in the region; and

(d) work with Symphony on strategic developments in the region.

 

Michael Laurier, CEO of Symphony said, "I am very pleased to welcome Quantum Leap Capital as a material shareholder in the Group and look forward to exploring new opportunities through their extended network to help expand and accelerate the global adoption of our many technologies. I am also pleased to be working with GCC Support Services in what is one of our main markets, the Middle East."

 

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus Capital Limited (Nominated Adviser and Broker)

David Foreman, Alexandra Campbell-Harris (Investment Banking)

Tel: +44 (0) 203 829 5000

 

The person responsible for arranging the release of this information is Michael Laurier, CEO of the Company.

 

NOTES TO EDITORS:

 

About Symphony Environmental Technologies plc

https://www.symphonyenvironmental.com

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

Symphony is a founder-member of The BPA (www.biodeg.org) and participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

Further information on the Group can be found at https://www.symphonyenvironmental.com and X

 @SymphonyEnv. See also Symphony on Instagram.

D2W TECHNOLOGY

Symphony has developed over 25 years a biodegradable plastic technology which addresses the problem of persistent microplastics, by turning ordinary plastic at the end of its service-life into a waxy substance which is biodegradable. It is then no longer a plastic and can be bioassimilated in the open environment in a similar way to a leaf without leaving microplastics behind. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world, much of which has been recycled. In some countries, oxo-biodegradable plastic is mandatory for short-life plastic products.

D2P TECHNOLOGY

Symphony has also developed practical and cost-effective ways to upgrade plastic products to provide protection against bacteria, viruses, fungi, insects, odours and fire. See www.d2p.net.

NbR TECHNOLOGY

 

First developed by Symphony in 2011, NbR is made with natural minerals to reduce the amount of fossil-derived polyethylene or polypropylene used for making plastic products. The products will also biodegrade safely in nature without leaving microplastics if they escape recycling and end up as litter in the open environment.

 

When NbR is used instead of normal polythene or polypropylene resins it will reduce the amount of fossil-derived plastic in the product by 20%, as well as cutting CO2 emissions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEANSPEDFSEEA
Date   Source Headline
28th Apr 20267:00 amRNSPre-Close Trading Update
7th Apr 20267:00 amRNS-RHSAC report
23rd Mar 20267:00 amRNSDirector/PDMR dealing - Bed & ISA
18th Feb 20268:28 amRNSNew consultancy agreement and grant of options
12th Jan 20267:00 amRNS-Rd2w Biodegradable Plastic Technology
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSHolding(s) in Company
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
17th Dec 20253:33 pmRNSTrading and Middle East operations update
28th Nov 20257:00 amRNS-RAlignment with BB-REG-NET's Recommendations
26th Nov 202510:25 amRNSExtension to Convertible Loan Agreements
10th Nov 20257:00 amRNS-RNew product launch, South Korea
29th Oct 20257:00 amRNS-RRoyal Society Study on Ocean Biodegradable Plastic
24th Oct 20257:00 amRNS-RCEO speaks at Argus Fertiliser Conference
16th Oct 20257:00 amRNS-RSuccessful attendance at the K-Show
30th Sep 20257:00 amRNSInterim Results for 6 Months Ended 30 June 2025
26th Sep 20257:00 amRNS-RCEO Speaks at US SPE Conference
19th Sep 20254:55 pmRNSEPA Ireland update
23rd Jul 20251:53 pmRNSResult of AGM
23rd Jul 20257:00 amRNSAGM Statement
8th Jul 202510:25 amRNSUpdate on Approval from the Republic of Ireland
25th Jun 20251:49 pmRNSHolding(s) in Company
23rd Jun 202512:37 pmRNSApproval of d2w products in Ireland
18th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
12th Jun 20257:00 amRNSPreliminary Results
11th Jun 202510:15 amRNSChange of Subscription Amount
5th Jun 20257:00 amRNSChange of Equity Subscriber
14th May 202511:50 amRNSHolding(s) in Company
8th May 202510:35 amRNSEquity Subscription
10th Apr 20259:00 amRNSExtended Scientific Study on Microplastics in Soil
9th Apr 202510:00 amRNSTransfer of Shareholding and Assignment of CLAs
11th Mar 20257:00 amRNS-RStudy Findings - No Trace of Microplastics
10th Mar 20252:21 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNS-RRuling on Biodegradable Plastic Legislation
23rd Dec 202412:39 pmRNSOption amendments & grant of options
1st Nov 202411:15 amRNSGrant of Options
9th Sep 20247:00 amRNSInterim Results for 6 Months Ended 30 June 2024
23rd Aug 20247:00 amRNSNotice of Results and Investor Presentation
28th Jun 202412:49 pmRNSResult of AGM
28th Jun 20247:00 amRNSAGM Statement
6th Jun 20243:33 pmRNSPosting of Annual Report and Notice of AGM
6th Jun 20243:29 pmRNSPreliminary Results
23rd Apr 20244:36 pmRNSHolding(s) in Company
19th Apr 202411:16 amRNSResult of GM
3rd Apr 20242:00 pmRNSDirector dealing
28th Mar 20244:23 pmRNSResult of PrimaryBid Offer
28th Mar 20242:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.